Basics Day One Biopharmaceuticals, Inc. IPO Date: May 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $773.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 2.83% Avg Daily Range (30 D): $0.15 | 2.22% Avg Daily Range (90 D): $0.15 | 2.26% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): 1.55M Avg Daily Volume (90 D): 1.29M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 112 Avg Trade Size (Sh.) (90 D): 99 Institutional Trades Total Inst.Trades: 1,522 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.82M Avg Closing Trade (30 D): $.94M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 135.06K     News Aug 5, 2025 @ 8:00 PM Day One Reports Second Quarter 2025 Financial Resu... Source: Day One Biopharmaceuticals Oct 22, 2024 @ 6:33 PM Global Cancer Antibody Drug Conjugates Market Size... Source: Kuick Research Jun 19, 2024 @ 2:29 PM Day One (DAWN) In-Licenses MabCare Cancer Candidat... Source: Zacks Equity Research Jun 18, 2024 @ 12:30 PM Day One Expands Pipeline with Potential First-in-C... Source: Day One Biopharmaceuticals, Inc. May 30, 2024 @ 12:30 PM Day One Announces Sale of Priority Review Voucher ... Source: Day One Biopharmaceuticals, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.95 $-.29 $-.35 Diluted EPS $-.95 $-.29 $-.35 Revenue $ 187.64M $ 33.91M $ 30.76M Gross Profit $ $ $ Net Income / Loss $ -41.59M $ M $ -36M Operating Income / Loss $ -111.74M $ -34.97M $ -41.07M Cost of Revenue $ $ $ Net Cash Flow $ -203.99M $ -89.35M $ M PE Ratio